Recurrent unprovoked venous thromboembolism in a young female patient with high levels of homocysteine

International Journal of Angiology

Volumn 21, Issue 2, 2012, Pages 95-98

  Sule, Ashish Anil ^a   Chin, Tay Jam ^a   Khien, Lee Hwei ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

antifactor Xa; cardiovascular risk factors; deep vein thrombosis; factor V Leiden; hypertension; thrombophilia

Indexed keywords

ENOXAPARIN; FOLIC ACID; HOMOCYSTEINE; WARFARIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; FEMALE; FEMORAL VEIN THROMBOSIS; HUMAN; HYPERHOMOCYSTEINEMIA; LEG SWELLING; LUNG EMBOLISM; POPLITEAL VEIN THROMBOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; VEIN THROMBOSIS;

EID: 84862884360     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0032-1315626     Document Type: Article

References (25)

1. Varga EA, Sturm AC, Misita CP, Moll S. Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease. Circulation: 2005; 111 19 e289 e293
2. Lonn E, Yusuf S, Arnold MJ., et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med: 2006; 354 15 1567 1577
3. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA: 1995; 274 13 1049 1057
4. Kang SS, Wong PW, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr: 1992; 12 279 298
5. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med: 1998; 338 15 1042 1050 (Pubitemid 128753793)
6. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D. eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York McGraw-Hill: 1995; 1279 1327
7. Carey MC, Donovan DE, FitzGerald O, McAuley FD. Homocystinuria. I. A clinical and pathological study of nine subjects in six families. Am J Med: 1968; 45 1 7 25
8. Malinow MR, Kang SS, Taylor LM., et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation: 1989; 79 6 1180 1188 (Pubitemid 19155752)
9. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke: 1990; 21 4 572 576 (Pubitemid 20141879)
10. Malinow MR, Sexton G, Averbuch M, Grossman M, Wilson O, Upson B. Homocyst(e)ine in daily practice: levels in coronary heart disease. Coron Artery Dis: 1990; 1 4 12
11. Mudd SH, Uhlendorf BW, Freeman JM, Finkelstein JD, Shih VE. Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity. Biochem Biophys Res Commun: 1972; 46 2 905 912
12. Erbe RW. Inborn errors of folate metabolism. In: Blakely RL, Whitehead VM. eds. Folate and Pterins: Nutritional, Pharmacological, and Physiological Aspects. New York Marcel Dekker: 1986; 413 425
13. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood: 1997; 90 1 1 11 (Pubitemid 27276540)
14. Wilcken DE, Gupta VJ. Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur J Clin Invest: 1979; 9 4 301 307 (Pubitemid 10137119)
15. Chauveau P, Chadefaux B, Coudé M., et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl: 1993; 41 S72 S77
16. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy. J Lab Clin Med: 1989; 114 5 473 501 (Pubitemid 19285567)
17. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol: 1996; 27 3 517 527 (Pubitemid 26081913)
18. Refsum H, Wesenberg F, Ueland PM. Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate. Cancer Res: 1991; 51 3 828 835
19. Ueland PM, Refsum H, Brattstrom L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr. ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York Marcel Dekker: 1992; 183 236
20. Ubbink JB, van der Merwe A, Delport R., et al. The effect of a subnormal vitamin B-6 status on homocysteine metabolism. J Clin Invest: 1996; 98 1 177 184 (Pubitemid 26243834)
21. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol: 1969; 56 1 111 128
22. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF. The mutation Ala677> Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost: 1997; 77 5 818 821 (Pubitemid 27239096)
23. Ma J, Stampfer MJ, Hennekens CH., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation: 1996; 94 10 2410 2416 (Pubitemid 26403566)
24. van Bockxmeer FM, Mamotte CD, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation: 1997; 95 1 21 23 (Pubitemid 27029937)
25. den Heijer M, Koster T, Blom HJ., et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med: 1996; 334 12 759 762 (Pubitemid 26089357)